CRISPR Therapeutics' (CRSP) CEO Sam Kulkarni on Cowen 42nd Annual Health Care Conference (Transcript)

CRISPR Therapeutics AG (NASDAQ:CRSP) Cowen 42nd Annual Health Care Conference March 7, 2022 10:30 AM ET Company Participants Sam Kulkarni – Chief Executive Officer Conference Call Participants Tyler Van Buren – Cowen Tyler Van Buren Good morning, everyone. And welcome to Cowen’s 42nd Annual Health Care Conference. My name is Tyler Van Buren. I’m a Senior Biotech Analyst here at Cowen. For this next session we have a fireside chat with CRISPR Therapeutics. It’s my pleasure to introduce Sam Kulkarni, the Chie ...